高阶伤口护理市场－全球产业规模、份额、趋势、机会与预测，按产品、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球进阶伤口护理市场价值为 111.8 亿美元，预计到 2030 年将达到 148 亿美元，预测期内复合年增长率为 4.75%。市场一直保持稳定成长，主要原因是慢性和急性伤口的日益普及、对创新伤口护理产品的需求不断增长以及医疗技术的不断进步。与传统方法相比，先进的伤口护理可提供更快、更有效的癒合效果，并在医院和家庭护理环境中被广泛采用。该领域提供多种产品，例如生物活性敷料、负压伤口治疗和其他高性能解决方案。儘管全球需求强劲，尤其是老龄人口和慢性病患者，但高昂的产品成本仍阻碍了价格敏感地区的更广泛采用。

关键市场驱动因素

胆道疾病发生率不断上升

主要市场挑战

高级伤口护理产品成本高昂

主要市场趋势

日益关注再生医学和生物製剂

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：先进伤口护理市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（保湿、抗菌、活性）
  • 按应用（慢性伤口、急性伤口）
  • 按最终使用者（医院、专科诊所、家庭医疗保健、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美高阶伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲高级伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区先进伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲高级伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲高阶伤口护理市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球进阶伤口护理市场：SWOT 分析

第 14 章：竞争格局

• Convatec Group PLC
• Smith+Nephew
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation.

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Advanced Wound Care Market was valued at USD 11.18 billion in 2024 and is projected to reach USD 14.80 billion by 2030, growing at a CAGR of 4.75% during the forecast period. The market has seen steady growth, largely driven by the increasing prevalence of chronic and acute wounds, the rising demand for innovative wound care products, and ongoing advancements in medical technology. Advanced wound care offers faster, more efficient healing outcomes compared to traditional methods and is widely adopted in both hospital and home care settings. The sector includes diverse offerings such as bioactive dressings, negative pressure wound therapy, and other high-performance solutions. Despite strong global demand, especially in aging populations and among those with chronic conditions, high product costs continue to hinder broader adoption in price-sensitive regions.

Key Market Drivers

Increasing Incidence of Biliary Diseases

The growing incidence of chronic and acute wounds is a central factor accelerating the global advanced wound care market. Globally, chronic wounds affect approximately 1.51 to 2.21 individuals per 1,000 people, representing a substantial segment of patients requiring long-term care. Chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are often linked to underlying conditions such as diabetes, cardiovascular disease, and obesity. These wounds typically do not respond to standard dressings and demand advanced treatment solutions like antimicrobial dressings, hydrogels, and negative pressure wound therapy to prevent severe complications. The increasing burden of noncommunicable diseases-accounting for over 43 million deaths in 2021-further elevates the demand for effective and technologically advanced wound care products across both developed and emerging markets.

Key Market Challenges

High Cost of Advanced Wound Care Products

A significant challenge to the expansion of the advanced wound care market is the high cost of products like negative pressure wound therapy systems and collagen-based dressings. These premium solutions often exceed the budget constraints of healthcare providers in low- and middle-income countries. The elevated price points not only restrict access for individual patients but also strain public health budgets and insurance systems, limiting adoption even in moderately developed regions. As affordability remains a barrier, companies must focus on creating cost-effective alternatives without compromising on efficacy to enhance market penetration.

Key Market Trends

Increasing Focus on Regenerative Medicine and Biologics

A notable trend shaping the advanced wound care market is the increasing integration of regenerative medicine and biologics into wound treatment. Solutions such as growth factors, stem cell therapies, and bioengineered dressings are gaining traction for their ability to promote faster healing, particularly in chronic wound cases. These biologic therapies address underlying healing deficiencies, offering improved outcomes and reducing complications. Healthcare providers are showing a growing preference for such high-efficacy treatments, and companies investing in these biologic-based innovations are poised to benefit from expanding market opportunities as demand for sophisticated, targeted therapies increases.

Key Market Players

• Convatec Group PLC
• Smith+Nephew
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation

Report Scope:

In this report, the Global Advanced Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Wound Care Market, By Product:

• Moist
• Antimicrobial
• Active

Advanced Wound Care Market, By Application:

• Chronic Wounds
• Acute Wounds

Advanced Wound Care Market, By End User:

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Advanced Wound Care Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Advanced Wound Care Market.

Available Customizations:

Global Advanced Wound Care market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Advanced Wound Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Moist, Antimicrobial, Active)
  • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Advanced Wound Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Advanced Wound Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Advanced Wound Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Advanced Wound Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Advanced Wound Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Advanced Wound Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Advanced Wound Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Advanced Wound Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Advanced Wound Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Advanced Wound Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Advanced Wound Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Advanced Wound Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Advanced Wound Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Advanced Wound Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Advanced Wound Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Advanced Wound Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Advanced Wound Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Advanced Wound Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Advanced Wound Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Advanced Wound Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Advanced Wound Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Advanced Wound Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Advanced Wound Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Advanced Wound Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Advanced Wound Care Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Convatec Group PLC
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Smith+Nephew
• 14.3. Molnlycke AB
• 14.4. B. Braun SE
• 14.5. 3M Company
• 14.6. Urgo Group
• 14.7. Coloplast Corp
• 14.8. Integra LifeSciences Corporation
• 14.9. Medline Industries, LP.
• 14.10.Boston Scientific Corporation.

15. Strategic Recommendations

16. About Us & Disclaimer